Search

Search Bar
01/10/2024 DEVELOPMENT AND CLINICAL VALIDATION OF LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY FOR INDIVIDUALIZED RUXOLITINIB ADJUSTMENT IN FUTURE CASES OF STEROID-REFRACTORY GRAFT-VERSUS-HOST DISEASE
Redondo, S, Costa, M, Moreno-Martinez, ME, Riba, M, Aso, O, Iranzo, E, Esquirol, A, Sierra, J, Briones, J, Martino, R, Zapico, E, Garcia-Cadenas, I. DEVELOPMENT AND CLINICAL VALIDATION OF LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY FOR INDIVIDUALIZED RUXOLITINIB ADJUSTMENT IN FUTURE CASES OF STEROID-REFRACTORY GRAFT-VERSUS-HOST DISEASE. BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).
01/10/2024 EFFICACY AND SAFETY OF REDUCED-DOSES OF POST-TRANSPLANT CYCLOPHOSPHAMIDE IN PERIPHERAL BLOOD STEM CELL TRANSPLANTATION OUTSIDE THE HAPLOIDENTICAL SETTING
Redondo, S, Arrufat, A, Esquirol, A, Saavedra, S, Arguello-Tomas, M, Caballero, AC, O ate, G, Garrido, A, Lopez, J, Miqueleiz, S, Portos, JM, Iranzo, E, Moreno-Martinez, ME, Riba, M, Sierra, J, Briones, J, Garc a-Cadenas, I, Martino, R. EFFICACY AND SAFETY OF REDUCED-DOSES OF POST-TRANSPLANT CYCLOPHOSPHAMIDE IN PERIPHERAL BLOOD STEM CELL TRANSPLANTATION OUTSIDE THE HAPLOIDENTICAL SETTING. BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).
01/10/2024 EVALUATION OF MENTAL HEALTH THROUGH AN EHEALTH PLATFORM IN THE MANAGEMENT OF ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS (MYMEDULA STUDY): DESCRIPTIVE ANALYSIS
Tobajas, E, Carretero, G, De Dios, A, Redondo, S, Vallv , M, Esquirol, A, Aso, O, Triquell, M, Moreno-Martinez, ME, Riba, M, Blasco, A, Martino, R, Gomis-Pastor, M, Garc a-Cadenas, I. EVALUATION OF MENTAL HEALTH THROUGH AN EHEALTH PLATFORM IN THE MANAGEMENT OF ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS (MYMEDULA STUDY): DESCRIPTIVE ANALYSIS. BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).
01/10/2024 MOBILE HEALTH IN THE MANAGEMENT OF ALLOGENIC STEM CELL TRANSPLANT RECIPIENTS (MY-MEDULA STUDY): PRELIMINARY RESULTS OF THE CLINICAL TRIAL
Redondo, S, De Dios, A, Vallve, M, Real, J, Triquell, M, Aso, O, Esquirol, A, Moreno-Martinez, M, Riba, M, Ruiz, J, Tobajas, E, Sierra, J, Briones, J, Martino, R, Gomis-Pastor, M, Garcia-Cadenas, I. MOBILE HEALTH IN THE MANAGEMENT OF ALLOGENIC STEM CELL TRANSPLANT RECIPIENTS (MY-MEDULA STUDY): PRELIMINARY RESULTS OF THE CLINICAL TRIAL. BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).
01/10/2024 NURSING ROLE IN IMPLEMENTING EHEALTH FOR ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS: INITIAL FINDINGS FROM THE MY-MEDULA STUDY'S RANDOMIZED CLINICAL TRIAL
Triquell, M, Redondo, S, De Dios, A, Vallv , M, Real, J, Esquirol, A, Martinez, EM, Riba, M, Tobajas, E, Sierra, J, Briones, J, Martino, R, Ruiz, J, Pastor, MG, Cadenas, IG, Aso, O. NURSING ROLE IN IMPLEMENTING EHEALTH FOR ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS: INITIAL FINDINGS FROM THE MY-MEDULA STUDY'S RANDOMIZED CLINICAL TRIAL. BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).
13/09/2024 A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT)
Domingos, V, Nezvalova-Henriksen, K, Dadkhah, A, Moreno-Martinez, ME, Ben Hassine, K, Pires, V, Kroeger, N, Bauters, T, Hassan, M, Duncan, N, Kalwak, K, Ansari, M, Langebrake, C, Admiraal, R. A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT). BONE MARROW TRANSPLANTATION. 2024; 59(12)DOI:10.1038/s41409-024-02413-0. PMID:39271948. IF:5.200(Q1/1D).
01/09/2024 Risk Factors Associated with Antibiotic Exposure Variability in Critically Ill Patients: A Systematic Review
Gras-Martín, L, Plaza-Diaz, A, Zarate-Tamames, B, Vera-Artazcoz, P, Torres, OH, Bastida, C, Soy, D, Ruiz-Ramos, J. Risk Factors Associated with Antibiotic Exposure Variability in Critically Ill Patients: A Systematic Review. Antibiotics-Basel. 2024; 13(9)DOI:10.3390/antibiotics13090801. PMID:39334976. IF:4.600(Q1/2D).
01/09/2024 Guide for the efficient and safe delivery of Telepharmacy
Collado-Borell, R, Gomis-Pastor, M, Rodríguez-Cabezas, M, Parro-Martín, A, Linares-Alarcón, A, Gutiérrez, E, González-Corominas, E, Fernández-Polo, A, Domínguez-Cantero, M, Arrondo-Velasco, A, Morillo-Verdugo, R. Guide for the efficient and safe delivery of Telepharmacy. Health Policy and Technology. 2024; 13(4)DOI:10.1016/j.hlpt.2024.100899. PMID:. IF:3.700(Q1/1D).